Timelo Investment Management’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.22M Buy
1,114,967
+135,000
+14% +$933K 5.7% 2
2025
Q4
$7.71M Buy
979,967
+376,428
+62% +$2.42M 2.74% 3
2025
Q3
$2.95M Sell
603,539
-237,117
-28% -$1.21M 1.11% 7
2025
Q2
$4.96M Sell
840,656
-150,339
-15% -$795K 6.68% 3
2025
Q1
$5.77M Buy
990,995
+79,234
+9% +$547K 16.97% 3
2024
Q4
$6.85M Buy
911,761
+159,954
+21% +$1.23M 4.81% 6
2024
Q3
$5.98M Buy
751,807
+25,912
+4% +$234K 3.74% 4
2024
Q2
$6.09M Sell
725,895
-129,951
-15% -$1.05M 3.46% 5
2024
Q1
$7.3M Buy
855,846
+244,088
+40% +$2.04M 2.77% 4
2023
Q4
$5.19M Sell
611,758
-61,400
-9% -$583K 4.53% 6
2023
Q3
$6.87M Sell
673,158
-58,500
-8% -$607K 9.03% 3
2023
Q2
$9.52M Sell
731,658
-24,521
-3% -$304K 6.57% 4
2023
Q1
$7.02M Buy
756,179
+89,600
+13% +$1.04M 6.9% 3
2022
Q4
$7.26M Buy
666,579
+28,600
+4% +$156K 5.36% 5
2022
Q3
$2.58M Sell
637,979
-204,101
-24% -$1.38M 2.98% 12
2022
Q2
$6.14M Buy
842,080
+64,250
+8% +$508K 5.58% 4
2022
Q1
$7M Sell
777,830
-117,600
-13% -$1.13M 5.09% 4
2021
Q4
$10.1M Buy
+895,430
New +$11.2M 5.38% 3

Other funds holding PROF

Timelo Investment Management's PROF Position: Q1 2026 in Review

Timelo Investment Management increased its Profound Medical (PROF) stake by 14% in Q1 2026, buying an estimated $933K and bringing the position to 1,114,967 shares worth $7.22M. The position accounts for 5.7% of the portfolio, ranked #2.

Timelo Investment Management first reported a position in PROF in Q4 2021 and has held it in 18 quarters since. The position peaked at $10.1M in Q4 2021. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Timelo Investment Management held 1,114,967 shares of Profound Medical worth $7.22M as of Q1 2026.
  • Timelo Investment Management bought 135,000 Profound Medical shares in Q1 2026, an estimated $933K.
  • Profound Medical made up 5.7% of Timelo Investment Management's portfolio in Q1 2026, its #2 holding.
  • Timelo Investment Management first reported a position in Profound Medical in Q4 2021 and has held it in 18 quarters since.
  • Timelo Investment Management's Profound Medical position peaked at $10.1M in Q4 2021.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Timelo Investment Management's 13F filing for Q1 2026, filed 14 May 2026.